Compare OTLY & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTLY | OFIX |
|---|---|---|
| Founded | 1994 | 1987 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.5M | 481.0M |
| IPO Year | 2021 | 1998 |
| Metric | OTLY | OFIX |
|---|---|---|
| Price | $14.18 | $10.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $14.50 | ★ $17.25 |
| AVG Volume (30 Days) | 210.5K | ★ 346.9K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | $7.91 | $6.13 |
| Revenue Next Year | $5.50 | $6.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $8.01 | $8.85 |
| 52 Week High | $18.84 | $16.99 |
| Indicator | OTLY | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 62.82 | 47.83 |
| Support Level | $10.47 | $8.99 |
| Resistance Level | $15.77 | $12.56 |
| Average True Range (ATR) | 0.58 | 0.56 |
| MACD | -0.16 | -0.11 |
| Stochastic Oscillator | 52.01 | 25.59 |
Oatly Group AB produces and distributes oat-based food and beverage products. Its offerings include milk, cooking creams, spreads, and yogurts. The company's products are sold through retail stores, coffee shops, and restaurants across multiple countries. It generates revenue from sales of oatmilk and other oat-based products. The company's geographical segments include Europe & International, North America and Greater China. The Europe & International segment is its maximum revenue-producing segment, followed by the North America and Greater China segments.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.